Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues
Current Oncology · 08.01.2023 · 30 (1) · 875-896
DOI: 10.3390/curroncol30010067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 08.01.2023. Verfasst von Luigi Marano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Surgical Oncology, Department of Medicine Surgery and Neurosciences, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite its decreasing incidence, gastric cancer remains an important global healthcare problem due to its overall high prevalence and high mortality rate. Since the MAGIC and FNLCC/FFCD trials, the neoadjuvant chemotherapy has been recommended throughout Europe in gastric cancer. Potential benefits of preoperative treatments include a higher rate of R0 resection achieved by downstaging the primary tumor, a likely effect on micrometastases and isolated tumor cells in the lymph nodes, and, as a result, improved cancer-related survival. Nevertheless, distortion of anatomical planes of dissection, interstitial fibrosis, and sclerotic tissue changes may increase surgical difficulty. The collection of at least twenty-five lymph nodes after neoadjuvant therapy would seem to ensure removal of undetectable node metastasis and reduce the likelihood of locoregional recurrence. It is not what you take but what you leave behind that defines survival. Therefore, para-aortic lymph node dissection is safe and effective after neoadjuvant chemotherapy, in both therapeutic and prophylactic settings. In this review, the efficacy of adequate lymph node dissection, also in a neoadjuvant setting, has been investigated in the key studies conducted to date on the topic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Surgical Oncology, Department of Medicine Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
ORCID-Profile: Luigi Marano, Ludovico Carbone, Valeria Restaino, Luigi Verre, Franco Roviello, Daniele Marrelli
Zitieren
APA
Marano, L., Carbone, L., Poto, G. E., Restaino, V., Piccioni, S. A., Verre, L., Roviello, F., & Marrelli, D. (2023). Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues. Current Oncology, 30(1), 875-896. https://doi.org/10.3390/curroncol30010067
Vancouver
Marano L, Carbone L, Poto GE, Restaino V, Piccioni SA, Verre L, et al. Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues. Current Oncology. 2023;30(1):875-896. doi:10.3390/curroncol30010067
BibTeX
@article{Marano2023,
author = {Marano, Luigi and Carbone, Ludovico and Poto, Gianmario Edoardo and Restaino, Valeria and Piccioni, Stefania Angela and Verre, Luigi and Roviello, Franco and Marrelli, Daniele},
title = {Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {1},
pages = {875--896},
doi = {10.3390/curroncol30010067}
}
EUVIMED